We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$205M
AUM Growth
+$35.6M
Cap. Flow
-$35.2M
Cap. Flow %
-17.19%
Top 10 Hldgs %
38.54%
Holding
227
New
51
Increased
39
Reduced
41
Closed
39

Top Buys

Rank Stock Value
1
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$2.06M
2
APPS icon
Digital Turbine
APPS
+$1.87M
3
MRK icon
Merck
MRK
+$1.39M
4
PFE icon
Pfizer
PFE
+$1.11M
5
BWEN icon
Broadwind
BWEN
+$1.05M

Top Sells

Rank Stock Value
1
DZSI
DZS Inc. Common Stock
DZSI
+$3.66M
2
ASPN icon
Aspen Aerogels
ASPN
+$2.95M
3
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$2.56M
4
EOLS icon
Evolus
EOLS
+$1.72M
5
INDI icon
indie Semiconductor
INDI
+$1.37M

Sector Composition

Rank Sector Weight
1 Technology 18.52%
2 Healthcare 17.49%
3 Financials 5.11%
4 Real Estate 2.52%
5 Industrials 2.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSK icon
26
GSK
GSK
$104B
$1.36M 0.66%
38,300
+6,402
+20% +$224K
BKTI icon
27
BK Technologies
BKTI
$300M
$1.19M 0.58%
83,202
– –
BCLI
28
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$1.18M 0.58%
+23,929
New +$694K
LPTH icon
29
Lightpath Technologies
LPTH
$651M
$1.18M 0.58%
836,962
+337,537
+68% +$524K
CVV icon
30
CVD Equipment Corp
CVV
$50M
$1.09M 0.53%
+82,139
New +$927K
PFE icon
31
Pfizer
PFE
$143B
$1.05M 0.51%
+25,700
New +$1.11M
ITI
32
DELISTED
Iteris, Inc.
ITI
$998K 0.49%
212,700
+17,987
+9% +$75.3K
CGTX icon
33
Cognition Therapeutics
CGTX
$79.6M
$993K 0.48%
501,719
– –
AIRG icon
34
Airgain
AIRG
$73.4M
$958K 0.47%
178,308
-1,000
-0.6% -$6.95K
BWEN icon
35
Broadwind
BWEN
$93.6M
$945K 0.46%
+246,000
New +$1.05M
DZSI
36
DELISTED
DZS Inc. Common Stock
DZSI
$910K 0.44%
115,333
-328,997
-74% -$3.66M
INFN
37
DELISTED
Infinera Corporation Common Stock
INFN
$889K 0.43%
114,534
-91,406
-44% -$665K
BMY icon
38
Bristol-Myers Squibb
BMY
$133B
$887K 0.43%
+12,800
New +$903K
BAC icon
39
Bank of America
BAC
$435B
$883K 0.43%
30,887
-25,308
-45% -$835K
PCGU
40
DELISTED
PG&E Corporation
PCGU
$876K 0.43%
6,111
+252
+4% +$35.1K
SCYX icon
41
SCYNEXIS
SCYX
$48.1M
$856K 0.42%
35,666
-23,760
-40% -$316K
LUV icon
42
Southwest Airlines
LUV
$22B
$789K 0.38%
24,251
+1,433
+6% +$48.7K
ENV
43
DELISTED
ENVESTNET, INC.
ENV
$760K 0.37%
12,961
-3,167
-20% -$197K
MKL icon
44
Markel Group
MKL
$23.3B
$742K 0.36%
+581
New +$772K
MDNA
45
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$685K 0.33%
1,053,808
-17,130
-2% -$10.7K
THER
46
DELISTED
THERATECHNOLOGIES INC COM
THER
$684K 0.33%
846,654
-105,370
-11% -$85.2K
NBIX icon
47
Neurocrine Biosciences
NBIX
$16.8B
$647K 0.32%
+6,393
New +$665K
WEAV icon
48
Weave Communications
WEAV
$520M
$640K 0.31%
128,701
+76,484
+146% +$384K
MCHP icon
49
Microchip Technology
MCHP
$40.3B
$592K 0.29%
7,070
-236
-3% -$18.8K
SPRB
50
Spruce Biosciences
SPRB
$118M
$581K 0.28%
+3,608
New +$670K
1
2
3 4 5

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
SCA
SMH Capital Advisors Fort Worth, Texas $32.9M AUM 1.53% 1-Year Est. Return

Worth Venture Partners's Q1 2023 Portfolio in Review

As of Q1 2023, Worth Venture Partners held 227 positions worth $205M, up 21% from $169M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Worth Venture Partners withdrew a net $35.2M in Q1 2023, closing 39 positions and reducing 41 holdings. Its most notable exit was Aspen Aerogels, an estimated $2.95M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Worth Venture Partners opened a new position in Marinus Pharmaceuticals, Inc worth $2.27M.

  • Worth Venture Partners's largest Q1 2023 buy was Marinus Pharmaceuticals, Inc: 328,735 shares worth $2.27M.
  • Worth Venture Partners added most to Digital Turbine in Q1 2023, an estimated $1.87M increase.
  • Worth Venture Partners's biggest Q1 2023 reduction was DZS Inc. Common Stock, cutting an estimated $3.66M.
  • Worth Venture Partners fully exited Aspen Aerogels in Q1 2023, selling an estimated $2.95M.
  • Worth Venture Partners's ten largest holdings make up 39% of its $205M portfolio in Q1 2023.
  • Worth Venture Partners opened 51 new positions and closed 39 in Q1 2023.
  • Worth Venture Partners's portfolio value rose 21% quarter-over-quarter to $205M.

Based on Worth Venture Partners's 13F filing for Q1 2023, filed 15 May 2023.